Starzl Network Patient Reported Outcomes
SPaRO
Starzl Network for Excellence in Pediatric Transplantation (SNEPT) Implementation of a QoL Measure in Pediatric Transplant Recipients
2 other identifiers
interventional
200
2 countries
7
Brief Summary
This study uses a smartphone application/web interface (RealTime Clinic; RTC) to collect patient and parent reports of a pediatric liver transplant recipient's quality of life (QOL), and examines the extent to which QOL evaluations can be integrated into care with the help of the application. The QOL measure that is used in this study is the Pediatric Liver Transplant Quality of Life (PeLTQL) questionnaire. Utilization, effectiveness, and efficiency data are evaluated. Hypotheses are fully described in the protocol. The primary hypothesis is that 80% of recruited child-proxy dyads will have at least one RTC-enabled PeLTQL score at 12 months. Other hypotheses look at implementation metrics and patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2022
CompletedFirst Posted
Study publicly available on registry
February 16, 2022
CompletedStudy Start
First participant enrolled
February 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedJanuary 8, 2026
January 1, 2026
2.1 years
January 22, 2022
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implementation metric
The proportion of participants who complete the Pediatric Liver Transplant Quality of Life (PeLTQL) measure (either parent or child), at least once
12 months
Secondary Outcomes (9)
Patient baseline quality of life (child report on PeLTQL)
Time of enrollment
Patient quality of life (child report on PeLTQL)
12 months post-enrollment
Proxy report of child's quality of life using PeLTQL
Time of enrollment
Proxy report of child's quality of life using PeLTQL
12 months post-enrollment
Medication level variability index (MLVI)
Calculated for year following implementation (12 month period following enrollment)
- +4 more secondary outcomes
Other Outcomes (1)
Rejection
24 months
Study Arms (1)
Pediatric liver transplant recipients
EXPERIMENTALAs this is a single arm trial, all eligible liver transplant recipients and their caregivers will be enrolled in this arm. Eligible participants are children who received a liver transplant at least 1 year prior to enrollment at a participating SNEPT center and continue to receive their post-transplant care at that center.
Interventions
Delivery of PeLTQL scoring information to clinicians via electronic means.
Eligibility Criteria
You may qualify if:
- The patient must meet all of below criteria to be eligible for enrollment in the study:
- The patient is \> 8 at enrollment and \< 20 years of age at 2 year post enrollment.
- The patient received a liver transplantation at least 1 year prior to enrollment.
- The patient and parent/ guardian have internet access either through a smartphone, tablet or computer.
- The patient and at least one guardian speaks English or Spanish at a level that allows them to understand the study procedures and consent to the study.
You may not qualify if:
- None of the following may be present if the patient is to be eligible for enrollment in the study:
- The patient is expected to transition to another service (e.g., adult clinic, another hospital) in the year following enrollment.
- The guardian or patient (in a developmentally-appropriate manner) do not understand the study procedures. This will be verified by asking both guardian and adolescent to repeat the study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icahn School of Medicine at Mount Sinaicollaborator
- Emory-Children's Centercollaborator
- University of Pittsburghlead
- The Hospital for Sick Childrencollaborator
- Columbia Universitycollaborator
- Seattle Children's Hospitalcollaborator
- University of San Franciscocollaborator
Study Sites (7)
UCSF Benioff Children's Hospital
Oakland, California, 94609, United States
Emory Children's
Atlanta, Georgia, 30322, United States
Columbia University Children's
New York, New York, 10027, United States
Mt. Sinai
New York, New York, 10029, United States
UPMC Children's
Pittsburgh, Pennsylvania, 15224, United States
Seattle Children's
Seattle, Washington, 98105, United States
Toronto Sick Kids
Toronto, Ontario, 10001, Canada
Related Publications (1)
Ng V, Nicholas D, Dhawan A, Yazigi N, Ee L, Stormon M, Gilmour S, Schreiber R, Taylor R, Otley A; PeLTQL study group. Development and validation of the pediatric liver transplantation quality of life: a disease-specific quality of life measure for pediatric liver transplant recipients. J Pediatr. 2014 Sep;165(3):547-55.e7. doi: 10.1016/j.jpeds.2014.05.024. Epub 2014 Jun 26.
PMID: 24976329BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eyal Shemesh, MD
Icahn School of Medicine at Mt. Sinai
- PRINCIPAL INVESTIGATOR
George Mazariegos, MD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery, Chief Pediatric Transplantation
Study Record Dates
First Submitted
January 22, 2022
First Posted
February 16, 2022
Study Start
February 28, 2022
Primary Completion
March 20, 2024
Study Completion
July 30, 2025
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share